Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT

Toxicology Letters

Volumn 208, Issue 2, 2012, Pages 168-173

  Marchand, Lucas S ^a,c   St Hilaire, Sophie ^a   Putnam, Elizabeth A ^b   Serve, Kinta M ^a   Pfau, Jean C ^a  

^a IDAHO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Amphibole; Autoimmune disease; Libby MT; Pleural

Indexed keywords

AMPHIBOLE; ANTIBODY; ANTINUCLEAR ANTIBODY; ASBESTOS; MESOTHELIAL CELL AUTOANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LONG TERM EXPOSURE; LUNG LESION; MAJOR CLINICAL STUDY; MALE; PLEURA DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ASBESTOSIS; ENVIRONMENTAL EXPOSURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MONTANA; PLEURAL DISEASES; YOUNG ADULT;

EID: 82055185576     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.10.024     Document Type: Article

References (31)

1. Anderson B.A., Dearwent S.M., Durant J.T., Dyken J.J., Freed J.A., Moore S.M., Wheeler J.S. Exposure pathway evaluations for sites that processed asbestos-contaminated vermiculite. Int. J. Hyg. Environ. Health 2005, 208:55-65.
2. Arnett F.C. Is scleroderma an autoantibody mediated disease?. Curr. Opin. Rheumatol. 2006, 18:579-581.
3. Bandli B.R., Gunter M.E. A review of scientific literature examining the mining history, geology, mineralogy, and amphibole asbestos health effects of Rainy creek igneous complex, Libby, Montana, USA. Inhal. Toxicol. 2006, 18:949-962.
4. Bernstein D.M., Chevalier J., Smith P. Comparison of Calidreia chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal. Toxicol. 2005, 17:427-449.
5. Blake D.J., Wetzel S.A., Pfau J.C. Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages. Toxicology 2008, 246:172-179.
6. Brown J.M., Pfau J.C., Pershouse M.A., Holian A. Silica, apoptosis, and autoimmunity. J. Immunotoxicol. 2004, 1:177-187.
7. Bunderson-Schelvan M., Pfau J.C., Crouch R., Holian A. Non-pulmonary outcomes of asbestos exposure. J. Toxicol. Environ. Health 2011, 14(1):122-152.
8. Chizzolini C., Raschi E., Rezzonico R., Testoni C., Mallone R., Gabrielli A., Facchini A., Del Papa N., Borghi M.O., Dayer J.M., Meroni P.L. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum. 2002, 46:1602-1613.
9. Cooper G.S., Gilbert K.M., Greidinger E.L., James J.A., Pfau J.C., Reinlib L., Rishardson B.C., Rose N.R. Recent advances and opportunities in research on Lupus: environmental Influences and mechanisms of disease. Environ. Health Perspect. 2008, 116:695-702.
10. Henault J., Robitaille G., Senecal J.L., Raymond Y. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerae I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum. 2006, 50:3265-3274.
11. Hess E.V. Environmental chemicals and autoimmune disease: cause and effect. Toxicology 2002, 181-182:65-70.
12. Kahaleh B. The microvascular endothelium in scleroderma. Reumatology (Oxford) 2008, 47(Suppl. 5):14-15.
13. Lange A., Smolik R., Zatonski W., Szymanska J. Autoantibodies and serum immunoglobulin levels in asbestos workers. Int. Arch. Arbeitsmed. 1974, 32:313-325.
14. McDonald J.C., Harris J., Armstrong B. Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Occup. Environ. Med. 2004, 61:363-366.
15. Meeker G.P., Bern A.M., Brownfield I.K., Lowers H.A., Sutley S.J., Hoefen T.M., Vance J.S. The composition and morphology of amphibole from the Rainy Creek Complex, near Libby, Montana. Am. Mineral. 2003, 88:1955-1969.
16. Mossman B.T., Bignon J., Corn M., Seaton A., Gee J.B. Asbestos: scientific developments and implications for public policy. Science 1990, 247:294-301.
17. Muñoz L.E., Lauber K., Schiller M., Manfredi A.A., Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 2010, 6:280-289.
18. Nicholson W.J., Perkel G., Selikoff I.J. Occupational exposure to asbestos: population at risk and projected mortality-1880-2030. Am. J. Ind. Med. 1982, 3:259-311.
19. Nigam S.K., Suthar A.M., Patel M.M., Karnik A.B., Dave S.K., Kashyap S.K., Venkaiah K. Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J. Med. Res. 1993, 98:274-277.
20. Noonan C.W., Pfau J.C., Larson T.C., Spence M.R. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health Perspect. 2006, 114:1243-1247.
21. Peipins L.A., Lewin M., Campolucci S., Lybarger J.A., Miller A., Middleton D., Weis C., Spence M., Black B., Kapil V. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ. Health Perspect. 2003, 111:1753-1759.
22. Pernis B., Vigliani E.C., Selikoff I.J. Rheumatoid factor in serum of individuals exposed to asbestos. Ann. NY Acad. Sci. 1965, 132:112-120.
23. Pfau J.C., Blake D.J., Fritzler M.J. Autoantibody profile of an asbestos-exposed population. Autoimmunity: Role, Regulation and Disorders 2008, 245-268. NOVA Science Publications, Hauppauge, NY. F. Columbus (Ed.).
24. Pfau J.C., Sentissi J.J., Weller G., Putnam E.A. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health Perspect. 2005, 113:25-30.
25. Sanchez V.C., Pietruska J.R., Miselis N.R., Hurt R.H., Kane A.B. Biopersistence and potential adverse health impacts of fibrous nanomatériaux: what have we learned from asbestos?. Rev. Nanomed. Nanobiotechnol. 2009, 1:511-529.
26. Tamura M., Liang D., Tokuyama T., Yoneda T., Kasuga H., Narita N., Sada K., Miyazaki R., Okada S. Study on the relationship between appearance of autoantibodies and chest X-ray findings of asbestos plant employees. Sangyo Igaku. 1993, 35:406-412.
27. Tamura M., Tokuyama T., Kasuga H., Yoneda T., Miyazaki R., Narita N. Study on correlation between chest X-P course findings and change in antinuclear antibody in asbestos plant employees. Sangyo Eiseigaku Zasshi 1996, 38:138-141.
28. Tan E.M., Feltkamp T.E., Smolen J.S., Butcher B., Dawkins R., Fritzler M.J., Gordaon T., Hardin J.A., Kalden J.R., Lahitia R.G., Maini R.N., McDougal J.S., Rothfield N.F., Smeenk R.J., Takasaki Y., Wiik A., Wilson M.R., Koziol J.A. Range of antinuclear antibodies in " healthy" individuals. Arthritis Rheum. 1997, 40:1601-1611.
29. Tomatis M., Turci F., Ceschino R., Riganti C., Gazzano E., Martra B., Ghigo D., Fubini B. High aspect ratio materials: role of surface chemistry vs. length in the historical " long and short amosite asbestos fibers" Inhal. Toxicol. 2010, 22:984-998.
30. Turner-Warwick M., Parkes W.R. Circulating rheumatoid and antinuclear factors in asbestos workers. Br. Med. J. 1970, 3:492-495.
31. Whitehouse A.C. Asbestos-related pleural disease due to tremolite associated with progressive loss of lung function: serial observations in 123 miners, family members, and residents of Libby, Montana. Am. J. Ind. Med. 2004, 46:219-225.